Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.592 USD | -2.05% |
|
-12.30% | -14.45% |
05-14 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
05-09 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.45% | 14.85M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.57B | |
-18.26% | 20.82B | |
-18.47% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Sensei Biotherapeutics, National Cancer Institute to Collaborate on SNS-101 Development; Shares Gain Premarket